Docs

Article

Quantifying the effect of delaying the second COVID-19 vaccine dose in England: a mathematical modelling study

The UK was the first country to start national COVID-19 vaccination programmes, initially administering doses 3 weeks apart. However, early evidence of high vaccine effectiveness after the first dose and the emergence of the SARS-CoV-2 alpha variant prompted the UK to extend the interval between doses to 12 weeks. In this study, researchers at the Jameel Institute, Imperial College London, aimed to quantify the effect of delaying the second vaccine dose in England.

Details

author(s)
Neil Ferguson
Anne Cori
publication date
9 February 2023
source
The Lancet
related programme
Jameel Institute
Link to publication
External link ->

Real-time classification of tumour and non-tumour tissue in colorectal cancer using diffuse reflectance spectroscopy and neural networks to aid margin assessment

|

International Journal of Surgery

Viral emissions into the air and environment after SARS-CoV-2 human challenge: a phase 1, open label, first-in-human study

|

The Lancet

Health, economic, and social Impacts of substandard and falsified medicines in Low- and Middle-Income Countries: A systematic review of methodological approaches

|

The American Journal of Tropical Medicine and Hygiene

Lessons from COVID-19 for rescalable data collection

|

The Lancet

Impact of proactive and reactive vaccination strategies for health-care workers against MERS-CoV: a mathematical modelling study

|

The Lancet

Diminishing benefits of urban living for children and adolescents’ growth and development

|

Nature

Quantifying the effect of delaying the second COVID-19 vaccine dose in England: a mathematical modelling study

|

The Lancet

Climate change and communicable diseases in the Gulf Cooperation Council (GCC) countries

|

Science Direct

Gaps in mobility data and implications for modelling epidemic spread: A scoping review and simulation study

|

Science Direct

Prevalence, awareness, treatment and control of hypertension in China, 2004-18: findings from six rounds of a national survey

|

British Medical Journal

The effect of universal testing and treatment for HIV on health-related quality of life – An analysis of data from the HPTN 071 (PopART) cluster randomised trial

|

Science Direct

Global disparities in SARS-CoV-2 genomic surveillance

|

Nature

We use cookies on our site.